Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHRNA7 anticorps (Middle Region)

CHRNA7 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN630113
  • Antigène Voir toutes CHRNA7 Anticorps
    CHRNA7 (Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7))
    Épitope
    • 15
    • 14
    • 8
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region
    Reactivité
    • 66
    • 38
    • 34
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    Humain
    Hôte
    • 56
    • 12
    • 2
    Lapin
    Clonalité
    • 56
    • 13
    Polyclonal
    Conjugué
    • 31
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CHRNA7 est non-conjugé
    Application
    • 57
    • 25
    • 13
    • 13
    • 13
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    CHRNA7 antibody was raised against the middle region of CHRNA7
    Purification
    Purified
    Immunogène
    CHRNA7 antibody was raised using the middle region of CHRNA7 corresponding to a region with amino acids VPTPDSGVVCGRMACSPTHDEHLLHGGQPPEGDPDLAKILEEVRYIANRF
    Top Product
    Discover our top product CHRNA7 Anticorps primaire
  • Indications d'application
    WB: 1.25 µg/mL
    Optimal conditions should be determined by the investigator.
    Commentaires

    CHRNA7 Blocking Peptide, catalog no. 33R-9739, is also available for use as a blocking control in assays to test for specificity of this CHRNA7 antibody

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CHRNA7 antibody in PBS
    Concentration
    Lot specific
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Antigène
    CHRNA7 (Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7))
    Autre désignation
    CHRNA7 (CHRNA7 Produits)
    Synonymes
    anticorps CHRNA7-2, anticorps NACHRA7, anticorps dZ70B1.1, anticorps Acra7, anticorps alpha7, anticorps BTX, anticorps NARAD, anticorps nAChRa7, anticorps CHRNA7, anticorps cholinergic receptor nicotinic alpha 7 subunit, anticorps neuronal acetylcholine receptor subunit alpha-7, anticorps cholinergic receptor, nicotinic, alpha 7 (neuronal), anticorps cholinergic receptor, nicotinic, alpha polypeptide 7, anticorps cholinergic receptor, nicotinic, alpha 7, anticorps CHRNA7, anticorps LOC100374356, anticorps chrna7, anticorps Chrna7, anticorps LOC100060521
    Sujet
    The protein encoded by CHRNA7 displays marked permeability to calcium ions and is a major component of brain nicotinic receptors that are blocked by, and highly sensitive to, alpha-bungarotoxin. Once this receptor binds acetylcholine, it undergoes an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. This gene is located in a region identified as a major susceptibility locus for juvenile myoclonic epilepsy and a chromosomal location involved in the genetic transmission of schizophrenia.
    Poids moléculaire
    56 kDa (MW of target protein)
    Pathways
    Synaptic Membrane
Vous êtes ici:
Support technique